Citius Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTXR and other ETFs, options, and stocks.

About CTXR

Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. 

CEO
Leonard L. Mazur
CEOLeonard L. Mazur
Employees
23
Employees23
Headquarters
Cranford, New Jersey
HeadquartersCranford, New Jersey
Founded
2007
Founded2007
Employees
23
Employees23

CTXR Key Statistics

Market cap
17.48M
Market cap17.48M
Price-Earnings ratio
-0.28
Price-Earnings ratio-0.28
Dividend yield
Dividend yield
Average volume
1.22M
Average volume1.22M
High today
$0.8436
High today$0.8436
Low today
$0.76
Low today$0.76
Open price
$0.81
Open price$0.81
Volume
501.05K
Volume501.05K
52 Week high
$2.48
52 Week high$2.48
52 Week low
$0.63
52 Week low$0.63

Stock Snapshot

With a market cap of 17.48M, Citius Pharmaceuticals(CTXR) trades at $0.78. The stock has a price-to-earnings ratio of -0.28.

During the trading session on 2026-03-18, Citius Pharmaceuticals(CTXR) shares reached a daily high of $0.84 and a low of $0.76. At a current price of $0.78, the stock is +2.7% higher than the low and still -7.5% under the high.

Trading activity shows a volume of 501.05K, compared to an average daily volume of 1.22M.

The stock's 52-week range extends from a low of $0.63 to a high of $2.48.

The stock's 52-week range extends from a low of $0.63 to a high of $2.48.

People also own

Based on the portfolios of people who own CTXR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.